Dr. Habil Khorakiwala has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Habil Khorakiwala, the promoter of Wockhardt Limited, has submitted a disclosure to the stock exchange under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This is a regulatory filing that requires promoters to disclose their shareholding details and any encumbrances (such as pledges) on their promoter-held shares. The exact contents of the disclosure — whether it involves any change in stake or pledge activity — are not specified in the filing headline. This is a routine compliance disclosure typically filed by promoters of listed companies.
Neutral in itself — this is a standard regulatory compliance filing. However, investors should look at the actual disclosure document to check for any changes in promoter shareholding or pledge creation/release, which could affect sentiment.